tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PSNL Stock Latest News

Personalis assumed with an Equal Weight at Morgan Stanley
The FlyPersonalis assumed with an Equal Weight at Morgan Stanley
24d ago
PSNL
Personalis Announces $100M Stock Offering Amendment
PremiumCompany Announcements
Personalis Announces $100M Stock Offering Amendment
26d ago
8K
PSNL
Personalis Sees Revised Reimbursement Rates for Cancer Tests
PremiumCompany Announcements
Personalis Sees Revised Reimbursement Rates for Cancer Tests
30d ago
8K
PSNL
Personalis price target raised to $9 from $5 at Morgan Stanley
PremiumThe Fly
Personalis price target raised to $9 from $5 at Morgan Stanley
1M ago
PSNL
Personalis price target raised to $12 from $6 at Guggenheim
PremiumThe Fly
Personalis price target raised to $12 from $6 at Guggenheim
1M ago
PSNL
Personalis price target raised to $13 from $10 at H.C. Wainwright
PremiumThe FlyPersonalis price target raised to $13 from $10 at H.C. Wainwright
1M ago
PSNL
Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
Premium
The Fly
Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
1M ago
JD
CNC
Personalis Secures Medicare Coverage for NeXT Personal MRD Test, Positioning for Growth in Underpenetrated $20 Billion Market
Premium
Ratings
Personalis Secures Medicare Coverage for NeXT Personal MRD Test, Positioning for Growth in Underpenetrated $20 Billion Market
1M ago
PSNL
Personalis Gains Medicare Coverage for Cancer Test
PremiumCompany Announcements
Personalis Gains Medicare Coverage for Cancer Test
1M ago
8K
PSNL
Personalis announces Medicare coverage of NeXT Personal test
PremiumThe Fly
Personalis announces Medicare coverage of NeXT Personal test
1M ago
PSNL
Personalis price target raised to $10 from $8.50 at H.C. Wainwright
PremiumThe Fly
Personalis price target raised to $10 from $8.50 at H.C. Wainwright
2M ago
PSNL
Personalis Earnings Call: Strategic Gains Amid Revenue Hurdles
PremiumCompany Announcements
Personalis Earnings Call: Strategic Gains Amid Revenue Hurdles
2M ago
PSNL
Personalis price target raised to $11 from $9 at Lake Street
PremiumThe FlyPersonalis price target raised to $11 from $9 at Lake Street
2M ago
PSNL
Personalis Reports Q3 2025 Financial Results
Premium
Company Announcements
Personalis Reports Q3 2025 Financial Results
2M ago
PSNL
Personalis reports Q3 EPS (24c), consensus (27c)
Premium
The Fly
Personalis reports Q3 EPS (24c), consensus (27c)
2M ago
PSNL
Personalis sees Q4 revenue $15.7M-$20.7M, consensus $21.8M
PremiumThe Fly
Personalis sees Q4 revenue $15.7M-$20.7M, consensus $21.8M
2M ago
PSNL
PSNL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PSNL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
PSNL
Personalis Inc. Advances TNBC Treatment with Innovative ctDNA Study
PremiumCompany Announcements
Personalis Inc. Advances TNBC Treatment with Innovative ctDNA Study
2M ago
PSNL
Personalis announces NeXT Personal data from AstraZeneca’s Phase 3 LAURA trial
PremiumThe Fly
Personalis announces NeXT Personal data from AstraZeneca’s Phase 3 LAURA trial
2M ago
AZN
PSNL
Personalis management to meet with Piper Sandler
PremiumThe FlyPersonalis management to meet with Piper Sandler
3M ago
PSNL
Personalis collaborates with Yale Cancer Center over CATE clinical trial
Premium
The Fly
Personalis collaborates with Yale Cancer Center over CATE clinical trial
4M ago
PSNL
Buy Rating for Personalis Driven by Promising Clinical Data and Strategic Reimbursement Efforts
Premium
Ratings
Buy Rating for Personalis Driven by Promising Clinical Data and Strategic Reimbursement Efforts
4M ago
PSNL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >